Theresa L. Werner

Also affiliated with Huntsman Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 4 papers. Top paper: “A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.”.

A randomized phase II study of cabozantinib and nivolumab versus nivolumab in recurrent endometrial cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.6010

N/A

0DataRank · unranked

29 citations

Daniela Matei, Panagiotis A. Konstantinopoulos, Matthew S. Block, Andrea Jewell, Stéphanie Gaillard +15 more

Combating subclonal evolution of resistant cancer phenotypes

UNC Libraries(2020)10.17615/hett-8q86

N/A

0DataRank · unranked

0 citations

Aaron R. Quinlan, Rachel E. Factor, Ryan M. Layer, Layla A. Anderson, David F. Jenkins +23 more

Discrepancies between tumor genomic profiling and germline genetic testing

ESMO Open(2022)10.1016/j.esmoop.2022.100526

N/A

0DataRank · unranked

21 citations

Cathryn Koptiuch, Samantha Greenberg, Wendy Kohlmann, Joanne Jeter, Sarah V. Colonna +8 more

The time is now to start molecular subtyping high-intermediate and high-risk endometrial cancers

International Journal of Gynecological Cancer(2022)10.1136/ijgc-2022-003709

N/A

0DataRank · unranked

2 citations

Britton Trabert, Theresa L. Werner, David K. Gaffney, Elke A. Jarboe, Robert Dood